Erika Carmel-Tech Ltd - Asset Resilience Ratio
Erika Carmel-Tech Ltd (ERKA) has an Asset Resilience Ratio of 0.87% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2025)
This chart shows how Erika Carmel-Tech Ltd's Asset Resilience Ratio has changed over time. See Erika Carmel-Tech Ltd (ERKA) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Liquid Assets Composition Over Time
This chart breaks down Erika Carmel-Tech Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ERKA market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 0% |
| Short-term Investments | ILA255.00K | 0.87% |
| Total Liquid Assets | ILA255.00K | 0.87% |
Asset Resilience Insights
- Limited Liquidity: Erika Carmel-Tech Ltd maintains only 0.87% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Erika Carmel-Tech Ltd Industry Peers by Asset Resilience Ratio
Compare Erika Carmel-Tech Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
VIROMED MEDICAL NA O.N.
XETRA:VME |
Medical Devices | 0.03% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186 |
Medical Devices | 0.84% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.30% |
|
Novacyt
PA:ALNOV |
Medical Devices | 0.02% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
Annual Asset Resilience Ratio for Erika Carmel-Tech Ltd (2022–2025)
The table below shows the annual Asset Resilience Ratio data for Erika Carmel-Tech Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.87% | ILA255.00K ≈ $683.65 |
ILA29.16 Million ≈ $78.17K |
-5.90pp |
| 2024-12-31 | 6.78% | ILA2.35 Million ≈ $6.31K |
ILA34.75 Million ≈ $93.16K |
-10.84pp |
| 2023-12-31 | 17.61% | ILA8.26 Million ≈ $22.15K |
ILA46.91 Million ≈ $125.76K |
-1.31pp |
| 2022-12-31 | 18.92% | ILA12.94 Million ≈ $34.69K |
ILA68.39 Million ≈ $183.34K |
-- |
About Erika Carmel-Tech Ltd
Erika Carmel-Tech Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It provides B-Cure Laser Classic, a non-invasive and safe medical device for the treatment of chronic and acute pain for home use; and B-Cure Laser Pro, a clinically proven, non-invasive and safe medical device for treatment of both acute and chronic conditions. T… Read more